CCN Family Proteins in Cancer: Insight Into Their Structures and Coordination Role in Tumor Microenvironment

Qingan Jia1, Binghui Xu1, Yaoyao Zhang1

  • 1Institute of Medical Research, Northwestern Polytechnical University, Xi'an, China.

Frontiers in Genetics
|April 9, 2021
PubMed

Insights

Targeting the Cellular Communication Network (CCN) protein family, which influences the tumor microenvironment (TME), may offer a novel cancer treatment strategy. Understanding CCN protein roles and expression is key to developing effective therapies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Tumor cells and the tumor microenvironment (TME) interact through critical signaling pathways, promoting cancer progression.
  • Targeting single molecules in this crosstalk has limited success; multi-targeting is complex and may cause side effects.
  • The Cellular Communication Network (CCN) protein family, comprising six scaffolding proteins, plays a role in governing the TME.

Purpose of the Study:

  • To review current knowledge on the structures and roles of CCN proteins in various cancers.
  • To analyze CCN mRNA expression and its varied relationship with cancer prognosis.
  • To explore the potential of targeting CCN proteins as an anti-cancer strategy by rebalancing the TME.

Main Methods:

  • Literature review of existing studies on CCN protein family structures and functions.
  • Analysis of CCN mRNA expression data across different cancer types.
  • Examination of the relationship between CCN protein expression and patient prognosis.

Main Results:

  • CCN proteins share similar structures and mutually regulate their functions within the TME.
  • CCN protein expression and its prognostic significance vary considerably across different cancer types.
  • Diverse TME and CCN truncated isoforms contribute to the discrepant functions of CCN proteins in cancer.

Conclusions:

  • The diverse roles of CCN proteins in cancer are influenced by the specific TME and the presence of various CCN isoforms.
  • Targeting CCN proteins to modulate the TME presents a promising therapeutic avenue for cancer treatment.
  • Further research into CCN protein regulation and isoform-specific functions is warranted for developing targeted therapies.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.2K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.1K
Cadherins in Tissue Organization01:19

Cadherins in Tissue Organization

The cadherins are a superfamily of cell adhesion molecules comprising over 180 variants, with specific tissues expressing a particular combination of cadherin types. Cadherins generally exhibit homophilic binding; i.e., cadherins on one cell bind to cadherins of the same or closely related type on another cell. Thus, cells of the same type have a specific affinity to bind to each other and sort themselves into clusters to form tissues.
Cell Sorting During Development
Cell sorting plays an...
3.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.0K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.2K